Bipolar disorder and resembling special psychopathological manifestations in multiple sclerosis: A review

Current Opinion in Psychiatry

Volumn 24, Issue 4, 2011, Pages 336-340

  Iacovides, Apostolos ^a   Andreoulakis, Elias ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

affect; bipolar; euphoria; mood; multiple sclerosis; pathological laughing and crying; pseudobulbar affect

Indexed keywords

AMANTADINE; AMITRIPTYLINE; CARBAMAZEPINE; CITALOPRAM; DEXTROMETHORPHAN; DULOXETINE; FLUOXETINE; INTERFERON; LAMOTRIGINE; LEVODOPA; LITHIUM; MIRTAZAPINE; NORTRIPTYLINE; QUINIDINE; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VENLAFAXINE;

ARTICLE; BIPOLAR DISORDER; COMORBIDITY; DEPRESSION; EUPHORIA; HUMAN; MENTAL DISEASE; MULTIPLE SCLEROSIS; PREVALENCE; PSEUDOBULBAR AFFECT;

BIPOLAR DISORDER; COMORBIDITY; EUPHORIA; HUMANS; MULTIPLE SCLEROSIS; PREVALENCE;

EID: 79958704902     PISSN: 09517367     EISSN: 14736578     Source Type: Journal    
DOI: 10.1097/YCO.0b013e328347341d     Document Type: Article

References (47)

1. Fermo SL, Barone R, Patti F, et al. Outcome of psychiatric symptoms presenting at onset of multiple sclerosis: a retrospective study. Mult Scler 2010; 16:742-748.
2. Patten SB, Beck CA, Williams JVA, et al. Major depression in multiple sclerosis. A population-based perspective. Neurology 2003; 61:1524-1527.
3. Perala J, Suvisaari J, Saarni SI, et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry 2007; 64:19-28. (Pubitemid 46041735)
4. Schiffer RB, Wineman NM, Weikamp LR. Association between affective bipolar disorder and multiple sclerosis. Am J Psychiatry 1986; 143:94-95. (Pubitemid 16185872)
5. Joffe RT, Lippert GP, Gray TA, et al. Mood disorder and multiple sclerosis. Arch Neurol 1987; 44:376-378. (Pubitemid 17044085)
6. Minden SL, Schiffer RB. Affective disorders in multiple sclerosis. Review and recommendations for clinical research. Arch Neurol 1990; 47:98-104.
7. Diaz-Olavarrieta C, Cummings JL, Velazquez J, Garcia de la Cadena C. Neuropsychiatric manifestations of multiple sclerosis. J Neuropsychiatry Clin Neurosci 1999; 11:51-57. (Pubitemid 29070664)
8. Edwards LJ, Constantinescu CS. A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic. Mult Scler 2004; 10:575-581. (Pubitemid 39207233)
9. Marrie RS, Horwitz R, Cutter G, et al. The burden of medical comorbidity in multiple sclerosis: frequent, underdiagnosed and undertreated. Mult Scler 2009; 15:385-392.
10. Jefferies K. The neuropsychiatry of multiple sclerosis. Adv Psychiatric Treat 2006; 12:214-220.
11. Brown ES. Effects of glucocorticoids on mood, memory and the hippocampus. Treatment and preventive therapy. Ann NY Acad Sci 2009; 1179:41-55.
12. Fragoso YD, Comini Frota ER, Lopes JS, et al. Severe depression, suicide attempts and ideation during the use of interferon beta by patients with multiple sclerosis. Clin Neuropharmacol 2010; 33:312-316.
13. Feinstein A, du Boulay G, Ron MA. Psychotic illness in multiple sclerosis. A clinical and magnetic resonance study. Br J Psychiatry 1992; 161:680-685.
14. Young CR, Weiss EL, Bowers MB Jr, Mazure CM. The differential diagnosis of multiple sclerosis and bipolar disorder. J Clin Psychiatry 1997; 58:123. (Pubitemid 27149254)
15. Fazzito MM, Jordy SS, Tilbery CP. Psychiatric disorders in multiple sclerosis patients. Arq Neuropsiquiatr 2009; 67:664-667.
16. Schiffer RB, Weitkamp LR, Wineman M, Guttormsen S. Multiple sclerosis and affective disorder. Family history, sex and HLA-DR antigens. Arch Neurol 1988; 45:1345-1348.
17. Modrego PJ, Ferrandez J. Familial multiple sclerosis with repetitive relapses of manic psychosis in two patients (mother and daughter). Behav Neurol 2000; 12:175-179. (Pubitemid 32843164)
18. Bozikas VP, Anagnostouli MC, Petrikis P, et al. Familial bipolar disorder and multiple sclerosis: a three-generation HLA family study. Prog Neuropharmacol Biol Psychiatry 2003; 27:835-839. (Pubitemid 36966766)
19. Ameis SH, Feinstein A. Treatment of neuropsychiatric conditions associated with multiple sclerosis. Expert Rev Neurotherapeutics 2006; 6:1555-1567. (Pubitemid 44690923)
20. Rabins PV. Euphoria in multiple sclerosis. In: Rao SM, editor. Neurobehavioral aspects of multiple sclerosis. New York: Oxford University Press; 1990. pp. 180-185.
21. Benedict RH, Bobholtz JH. Multiple sclerosis. Semin Neurol 2007; 27:78-85. (Pubitemid 46239042)
22. Ron MA, Callanan MM, Warrington EK. Cognitive abnormalities in multiple sclerosis: a psychometric and MRI study. Psychol Med 1991; 21:59-68.
23. Sanfilipo MP, Benedict RH, Weinstock-Guttman B, Bakshi R. Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis. Neurology 2006; 66:685-692. (Pubitemid 43739822)
24. Robinson RG, Parikh RM, Lipsey JR, et al. Pathological laughing and crying following stroke: validation of a measurement scale and a double-blind treatment study. Am J Psychiatry 1993; 150:286-293. (Pubitemid 23046517)
25. Parvizi J, Archiniegas DB, Bernardini GL, et al. Diagnosis and management of pathological laughter and crying. Mayo Clin Proc 2006; 81:1482-1486. (Pubitemid 44685013)
26. Haussleiter IS, Brune M, Juckel G. Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment. Therapeutic Advances in Neurological Disorders 2009; 2:13-29.
27. Strowd RE, Cartwright MS, Okun MS, et al. Pseudobulbar affect: prevalence and quality of life impact in movement disorders. J Neurol 2010; 257:1382-1387.
28. Feinstein A, OConnor P, Gray T, Feinstein KJ. The prevalence and neurobehavioral correlates of pathological laughing and crying in multiple sclerosis. Arch Neurol 1997; 54:1116-1121. (Pubitemid 27396479)
29. Black DW. Pathological laughter: a review of the literature. J Nerv Ment Dis 1982; 170:67-71.
30. Feinstein A, OConnor P, Gray T, Feinstein KJ. Pathological laughing and crying in multiple sclerosis: a preliminary report suggesting a role for the prefrontal cortex. Mult Scler 1999; 5:69-73. (Pubitemid 29186822)
31. Parvizi J, Anderson SW, Martin CO, et al. Pathological laughter and crying: a link to the cerebellum. Brain 2001; 124:1708-1719. (Pubitemid 32845433)
32. Okun MS, Raju DJ, Walter BL, et al. Pseudobulbar crying induced by stimulation in the region of the subthalamic nucleus. J Neurol Neurosurg Psychiatry 2004; 75:921-923. (Pubitemid 38658524)
33. Ghaffar O, Chamelian L, Feinstein A. Neuroanatomy of pseudobulbar affect: a quantitative MRI study in multiple sclerosis. J Neurol 2008; 255: 406-412.
34. Panitch HS, Thisted RA, Smith RA, et al. Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis. Ann Neurol 2006; 59:780-787. (Pubitemid 43673155)
35. Parvizi J, Coburn KL, Shillcutt SD, et al. Neuroanatomy of pathological laughing and crying: A report of the American Neuropsychiatric Association Committee on Research. J Neuropsychiatry Clin Neurosci 2009; 21:75-87.
36. Wortzel HS, Oster TJ, Anderson CA, Archiniegas DB. Pathological laughing and crying: epidemiology, pathophysiology and treatment. CNS Drugs 2008; 22:531-545. (Pubitemid 351822116)
37. Udaka F, Yamao S, Nagata H, et al. Pathologic laughing and crying treated with levodopa. Arch Neurol 1984; 41:1095-1096. (Pubitemid 14041755)
38. Schiffer RB, Herndon RM, Rudick RA. Treatment of pathologic laughing and weeping with amitriptyline. New Engl J Med 1985; 312:1480-1482. (Pubitemid 15059233)
39. Seliger GM, Hornstein A, Flax J, et al. Fluoxetine improves emotional incontinence. Brain Inj 1992; 6:267-270.
40. Andersen G, Vestergaard K, Riis JO. Citalopram for poststroke pathological crying. Lancet 1993; 342:837-839.
41. Burns A, Russel E, Stratton-Powell H, et al. Sertraline in stroke-associated lability of mood. Int J Geriatr Psychiatry 1999; 14:681-685. (Pubitemid 29403287)
42. Ferentinos P, Paparrigopoulos T, Rentzos M, Evdokimidis I. Duloxetine for pathological laughing and crying. Int J Neuropsychopharmacol 2009; 12:1429-1430.
43. Smith AG, Montealegre-Orjuella M, Douglas JE, Jenkins EA. Venlafaxine for pathological crying after stroke. J Clin Psychiatry 2003; 64:731-732.
44. Moller M, Andersen G. Inhibition of selective noradrenergic reuptake as treatment of pathological laughter. J Clin Psychopharmacol 2007; 27: 108-110. (Pubitemid 46105786)
45. Kim SW, Shin IS, Kim JM, et al. Mirtazapine treatment for pathological laughing and crying after stroke. Clin Neuropharmacol 2005; 28:249-251.
46. Nahas Z, Arlinghaus KA, Kotrla KJ, et al. Rapid response of emotional incontinence to selective serotonin reuptake inhibitors. J Neuropsychiatry Clin Neurosci 1998; 10:453-455. (Pubitemid 28505398)
47. Ramasubbu R. Lamotrigine treatment for poststroke pathological laughing and crying. Clin Neuropharmacol 2003; 26:233-235. (Pubitemid 37221633)